Enanta Pharmaceuticals
ENTA
ENTA
110 hedge funds and large institutions have $220M invested in Enanta Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 31 reducing their positions, and 7 closing their positions.
Holders
110
Holders Change
+10
Holders Change %
+10%
% of All Funds
1.59%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
17
Increased
39
Reduced
31
Closed
7
Calls
$54K
Puts
$49K
Net Calls
+$5K
Net Calls Change
-$67K
Top Buyers
Top Sellers
| 1 |
CP
1
Caligan Partners
New York
|
$3.34M |
| 2 |
2
Morgan Stanley
New York
|
$11.4M |
| 3 |
BFM
3
Boothbay Fund Management
New York
|
$1.55M |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$5.56M |
| 5 |
5
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$1.49M |
